Cargando…

Serum Cytokine Profile, Beta-Hexosaminidase A Enzymatic Activity and GM(2) Ganglioside Levels in the Plasma of a Tay-Sachs Disease Patient after Cord Blood Cell Transplantation and Curcumin Administration: A Case Report

Tay-Sachs disease (TSD) is a progressive neurodegenerative disorder that occurs due to a deficiency of a β hexosaminidase A (HexA) enzyme, resulting in the accumulation of GM(2) gangliosides. In this work, we analyzed the effect of umbilical cord blood cell transplantation (UCBCT) and curcumin admin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaimardanova, Alisa A., Chulpanova, Daria S., Solovyeva, Valeriya V., Garanina, Ekaterina E., Salafutdinov, Ilnur I., Laikov, Alexander Vladimirovich, Kursenko, Vadim V., Chakrabarti, Lisa, Zakharova, Ekaterina Yu., Bukina, Tatiana M., Baydakova, Galina V., Rizvanov, Albert Anatolyevich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539434/ https://www.ncbi.nlm.nih.gov/pubmed/34685379 http://dx.doi.org/10.3390/life11101007

Ejemplares similares

New Approaches to Tay-Sachs Disease Therapy
por: Solovyeva, Valeriya V., et al.
Publicado: (2018)

Functionality of a bicistronic construction containing HEXA and HEXB genes encoding β-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses
por: Shaimardanova, Alisa A., et al.
Publicado: (2021)

Increasing β-hexosaminidase A activity using genetically modified mesenchymal stem cells
por: Shaimardanova, Alisa A., et al.
Publicado: (2023)

Tay–Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum–associated degradation
por: Dersh, Devin, et al.
Publicado: (2016)

Enfermedad de Tay Sachs
por: Cibrián Cruz, José Alberto
Publicado: (1996)

Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease
por: Kodama, Takashi, et al.
Publicado: (2011)

sp(2)-Iminosugars targeting human lysosomal β-hexosaminidase as pharmacological chaperone candidates for late-onset Tay-Sachs disease
por: González-Cuesta, Manuel, et al.
Publicado: (2022)

Comparative Analysis of Natural and Cytochalasin B-Induced Membrane Vesicles from Tumor Cells and Mesenchymal Stem Cells
por: Gilazieva, Zarema, et al.
Publicado: (2022)

Therapeutic Strategies For Tay-Sachs Disease
por: Picache, Jaqueline A., et al.
Publicado: (2022)

Analysis of Brain Lipids in the Early-Onset Tay–Sachs Disease Mouse Model With the Combined Deficiency of β-Hexosaminidase A and Neuraminidase 3
por: Can, Melike, et al.
Publicado: (2022)

Neuraminidase-1 contributes significantly to the degradation of neuronal B-series gangliosides but not to the bypass of the catabolic block in Tay–Sachs mouse models
por: Timur, Z.K., et al.
Publicado: (2015)

Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis
por: Chulpanova, Daria S., et al.
Publicado: (2022)

Extracellular vesicles in the diagnosis and treatment of central nervous system diseases
por: Shaimardanova, Alisa A., et al.
Publicado: (2019)

Proangiogenic Effect of 2A-Peptide Based Multicistronic Recombinant Constructs Encoding VEGF and FGF2 Growth Factors
por: Gatina, Dilara Z., et al.
Publicado: (2021)

Characterization of Inducible Models of Tay-Sachs and Related Disease
por: Sargeant, Timothy J., et al.
Publicado: (2012)

Choroidal Coloboma in a Case of Tay-Sachs Disease
por: Ahmed, Nasreen Raees, et al.
Publicado: (2014)

Tay-Sachs disease: current perspectives from Australia
por: Lew, Raelia M, et al.
Publicado: (2015)

GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease
por: Demir, Seçil Akyıldız, et al.
Publicado: (2020)

Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches
por: Shaimardanova, Alisa A., et al.
Publicado: (2020)

Cytochalasin B-Induced Membrane Vesicles from Human Mesenchymal Stem Cells Overexpressing IL2 Are Able to Stimulate CD8(+) T-Killers to Kill Human Triple Negative Breast Cancer Cells
por: Chulpanova, Daria S., et al.
Publicado: (2021)

The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity
por: Chulpanova, Daria S., et al.
Publicado: (2022)

Safety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs
por: Mullagulova, Aysilu, et al.
Publicado: (2023)

Gene and Cell Therapy for Epilepsy: A Mini Review
por: Shaimardanova, Alisa A., et al.
Publicado: (2022)

Prenatal diagnosis of Tay-Sachs disease: our institutional experience
por: Sheth, Jayesh, et al.
Publicado: (2014)

Neurodegeneration with Progressive Dystonia: Juvenile-Onset Tay–Sachs Disease
por: Kaur, Jasmine, et al.
Publicado: (2022)

Late-Onset Tay-Sachs Disease - expanding the clinical phenotype
por: Lefter, Stela, et al.
Publicado: (2023)

Genetically Engineered Artificial Microvesicles Carrying Nerve Growth Factor Restrains the Progression of Autoimmune Encephalomyelitis in an Experimental Mouse Model
por: Alatrash, Reem, et al.
Publicado: (2023)

Production and Application of Multicistronic Constructs for Various Human Disease Therapies
por: Shaimardanova, Alisa A., et al.
Publicado: (2019)

Expanding the spectrum of HEXA mutations in Indian patients with Tay–Sachs disease
por: Sheth, Jayesh, et al.
Publicado: (2014)

Gene Therapy of Sphingolipid Metabolic Disorders
por: Shaimardanova, Alisa A., et al.
Publicado: (2023)

Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
por: Issa, Shaza S., et al.
Publicado: (2023)

Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells
por: Chulpanova, Daria S., et al.
Publicado: (2022)

Tay-Sachs' Disease: A Study of the Symptomatology and Pathology of Three Atypical Cases
por: Torrance, Herbert Watt
Publicado: (1922)

Tay-Sachs' Disease: A Study of the Symptomatology and Pathology of Three Atypical Cases
por: Torrance, Herbert Watt
Publicado: (1922)

Tay-Sachs' Disease: A Study of the Symptomatology and Pathology of Three Atypical Cases
por: Torrance, Herbert Watt
Publicado: (1922)

Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease
por: Vu, Mylinh, et al.
Publicado: (2018)

Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model
por: Sengul, Tugce, et al.
Publicado: (2023)

Nursing Care Plan for Patients with Tay–Sachs—A Rare Paediatric Disease
por: Cortés-Martín, Jonathan, et al.
Publicado: (2023)

Human Mesenchymal Stem Cells Overexpressing Interleukin 2 Can Suppress Proliferation of Neuroblastoma Cells in Co-Culture and Activate Mononuclear Cells In Vitro
por: Chulpanova, Daria S., et al.
Publicado: (2020)

Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders
por: Issa, Shaza S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b4cdjg05m8oat47ut71okordp3